Publication | Closed Access

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Iressa Survival EvaluationMedicineCancer ManagementBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerBest Supportive Care